Teladoc Health Inc banner

Teladoc Health Inc
F:4LL

Watchlist Manager
Teladoc Health Inc Logo
Teladoc Health Inc
F:4LL
Watchlist
Price: 6.54 EUR 5.48% Market Closed
Market Cap: €1.1B

Teladoc Health Inc
Investor Relations

Teladoc Health is a telehealth company that connects patients with doctors, therapists, and other clinicians through phone, video, and app-based visits. It helps people get care for common medical issues, mental health support, and some chronic-condition management without going to a clinic first. Its main customers are employers, health plans, hospitals, and individual members who use its services through those organizations or directly. Teladoc makes money by charging subscription or access fees for its care programs, plus fees tied to virtual visits and other service contracts. What makes Teladoc different is that it sits in the middle of the healthcare system as a care access layer rather than a traditional provider, insurer, or drug company. Its business depends on building a large network of clinicians and software tools that make medical advice and follow-up care easier to reach from anywhere.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Apr 29, 2026
AI Summary
Q1 2026

Beat and hold: Teladoc said Q1 consolidated revenue and adjusted EBITDA came in above the midpoint of guidance, with results helped by solid Integrated Care execution and early progress in BetterHelp insurance.

Integrated Care shift: Management said the business is moving from subscription-based access to visit-based arrangements, which hurt near-term revenue but is expected to become a net tailwind later in 2026.

BetterHelp momentum: Insurance rollout is progressing ahead of expectations, with 30 states plus Washington, D.C., more than 6,000 credentialed providers, and an expected exit rate of at least $125 million in annualized insurance revenue.

Guidance steady: Full-year revenue, adjusted EBITDA and free cash flow guidance were reaffirmed at the midpoint, while BetterHelp revenue guidance was narrowed and insurance revenue expectations were raised.

AI and product push: Teladoc is investing in AI-enabled tools and new products, including Pulse intelligence and Prism enhancements, and expects new comprehensive offerings later this year.

Cost discipline: Management emphasized operating discipline, cost savings and productivity efforts, while also planning to address 2027 convertible notes in two phases to reduce gross debt.

Key Financials
Consolidated revenue
$614 million
Adjusted EBITDA
$58 million
Net loss per share
$0.36
Free cash flow
net outflow of $26 million
Cash and cash equivalents
$751 million
Net debt to trailing adjusted EBITDA
under 0.9x
Gross debt to trailing adjusted EBITDA
3.6x
Integrated Care revenue
$395 million
Integrated Care adjusted EBITDA
$56 million
U.S. Integrated Care membership
101.2 million members
Chronic Care program enrollment
1.2 million
BetterHelp revenue
$218 million
BetterHelp insurance revenue
$13 million
BetterHelp average paying users
361,000
BetterHelp adjusted EBITDA
$2 million
BetterHelp insurance covered sessions
over 14,000 per week
BetterHelp contracted lives
over 150 million
Credentialed and enrolled providers
over 6,000
Stock-based compensation expense
below $55 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael Waters
Chief Operating Officer
No Bio Available
Mr. Adam Christian Vandervoort J.D.
Chief Legal Officer & Secretary
No Bio Available
Dr. George Byron Brooks
Co-Founder
No Bio Available
Mr. Joseph Ronald Catapano Cpa
Senior VP & Chief Accounting Officer
No Bio Available
Mr. Nikolaos Nanis
Chief Technology Officer
No Bio Available
Mr. Patrick Thomas Feeley C.F.A., CPA
Vice President of Investor Relations
No Bio Available
Mr. Andrew Turitz
Executive Vice President of Corporate Development
No Bio Available
Mr. Arnnon Geshuri
Chief People Officer
No Bio Available
Mr. Daniel Trencher
Chief Strategy Officer
No Bio Available
Mr. Carlos Nueno
President of International
No Bio Available

Contacts

Address
NEW YORK
Purchase
2 Manhattanville Rd Ste 203
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett